Leadership grounded in decades of therapeutic innovation.

INVENT Pharmaceuticals is led by visionary and experienced leadership with decades of experience from world-class biotech and pharmaceutical companies. Our team brings broad and deep cross-functional expertise across management, science and technology driving the innovative design, discovery and development of novel therapeutics to help patients.

Dale Dhanoa, Ph.D.

Dr. Dale Dhanoa is the President, CEO and Founder of INVENT Pharmaceuticals and brings more than 25 years of leadership experience across research and development, drug design and discovery, company operations management and strategic partnering from biotech and pharmaceutical companies.

Over the course of his career, Dr. Dhanoa has led discovery and development of innovative therapeutics, business and corporate development. His experience includes senior and executive leadership and management positions at Predix Pharmaceuticals, Synaptic Pharmaceuticals, Alanex Corporation (acquired by Agouron and later became part of Pfizer) and 3- Dimensional Pharmaceuticals (acquired by J&J), Akaal Pharma and PharmaCore.

Dr. Dhanoa began his career at Merck Research Laboratories of Merck & Co., in Rahway, NJ, and has contributed to multiple successful biotech financings, IPOs, strategic partnerships, and M&A transactions throughout. He has established collaborations with leading pharmaceutical organizations around the world, including Novartis, Roche, Novo Nordisk, Merck KGaA, Bristol Myers Squibb, Johnson & Johnson, AstraZeneca, Amgen, and Boehringer Ingelheim.

https://www.linkedin.com/in/daledhanoa/

Previous Strategic Partnerships and Collaborations